Citation Impact
Citing Papers
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
2010 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense
2016 Standout
Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America
2009 Standout
Epidemiology of and Diagnostic Strategies for Toxoplasmosis
2012 Standout
Management of opportunist mycobacterial infections: Joint Tuberculosis Committee guidelines 1999
2000
Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomised, placebo-controlled trial
2011
Early Versus Delayed Antiretroviral Therapy and Cerebrospinal Fluid Fungal Clearance in Adults With HIV and Cryptococcal Meningitis
2013 StandoutNobel
Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk
2013 Standout
AIDS-Related Mycobacterium kansasii Infection with Initial Resistance to Clarithromycin
1998
A Randomized, Placebo‐Controlled Study of Rifabutin Added to a Regimen of Clarithromycin and Ethambutol for Treatment of Disseminated Infection with Mycobacterium avium Complex
1999
Initial (6-Month) Results of Three-Times-Weekly Azithromycin in Treatment Regimens for Mycobacterium avium Complex Lung Disease in Human Immunodeficiency Virus-Negative Patients
1998
Antibiotic Treatment ofChlamydia pneumoniaeafter Acute Coronary Syndrome
2005 Standout
NONTUBERCULOUS MYCOBACTERIAL INFECTIONS
1997
Randomized, Open‐Label Trial of Azithromycin Plus Ethambutol vs. Clarithromycin Plus Ethambutol as Therapy forMycobacterium aviumComplex Bacteremia in Patients with Human Immunodeficiency Virus Infection
1998
Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis
2017 Standout
The Role of Advanced Generation Macrolides in the Prophylaxis and Treatment of Mycobacterium avium Complex (MAC) Infections
1997
A Prospective, Randomized Trial Examining the Efficacy and Safety of Clarithromycin in Combination with Ethambutol, Rifabutin, or Both for the Treatment of Disseminated Mycobacterium avium Complex Disease in Persons with Acquired Immunodeficiency Syndrome
2003
Antiangiogenic and antitumor effects of 14-membered ring macrolides on mouse B16 melanoma cells
1999
Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy
2008
Long-term Follow-up of Mycobacterium avium Complex Lung Disease in Patients Treated With Regimens Including Clofazimine and/or Rifampin
2015
Azithromycin Activity Against Mycobacterium avium Complex Lung Disease in Patients Who Were Not Infected with Human Immunodeficiency Virus
1996
First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol
2001
Guidelines on Prevention, Diagnosis and Treatment of Infective Endocarditis Executive Summary The Task Force on Infective Endocarditis of the European Society of Cardiology
2004 Standout
Septic arthritis affecting pubic symphysis: Figure 1
2011
Q Fever Endocarditis in Israel and a Worldwide Review
1997
Azithromycin for the Secondary Prevention of Coronary Events
2005
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
2006 Standout
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
2017 Standout
Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes
2007 Standout
The therapeutic approach to non-tuberculous mycobacterial infection of the lung
2010
Tuberculosis in Patients with Human Immunodeficiency Virus Infection
1999 Standout
Nontuberculous Mycobacterial Immune Reconstitution Syndrome in HIV-Infected Patients: Spectrum of Disease and Long-Term Follow-Up
2005
Management of opportunist mycobacterial infections: Joint Tuberculosis Committee guidelines 1999
2000
PCR detection of Toxoplasma gondii DNA in CSF for the differential diagnosis of AIDS-related focal brain lesions
1996
Proinflammatory Cytokine and Human Immunodeficiency Virus RNA Levels during EarlyMycobacterium aviumComplex Bacteremia in Advanced AIDS
1998
Clinical and Microbiologic Outcomes in Patients Receiving Treatment for Mycobacterium abscessus Pulmonary Disease
2011 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Nontuberculous Mycobacteria in Solid Organ Transplant Recipients
2009
Malaria
2013 Standout
Treatment outcomes of refractory MAC pulmonary disease treated with drugs with unclear efficacy
2014
Discontinuation of Prophylaxis againstMycobacterium aviumComplex Disease in HIV-Infected Patients Who Have a Response to Antiretroviral Therapy
2000
Prospective Randomized Trial of Four Three‐Drug Regimens in the Treatment of DisseminatedMycobacterium aviumComplex Disease in AIDS Patients: Excess Mortality Associated with High‐Dose Clarithromycin
1999
Prophylaxis against Opportunistic Infections in Patients with Human Immunodeficiency Virus Infection
2000
Outcomes of clofazimine for the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis
2012
Structural Basis for the Antibiotic Activity of Ketolides and Azalides
2003 StandoutNobel
Trends in Mortality Due to Invasive Mycotic Diseases in the United States, 1980–1997
2001
Prevalence of Cryptococcal Antigenemia and Cost-Effectiveness of a Cryptococcal Antigen Screening Program – Vietnam
2013
Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS
2009 Standout
EM703, the new derivative of erythromycin, inhibits transcription of type I collagen in normal and scleroderma fibroblasts
2007 StandoutNobel
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 Standout
Cost Effectiveness of Cryptococcal Antigen Screening as a Strategy to Prevent HIV-Associated Cryptococcal Meningitis in South Africa
2013
Mycobacterium avium complex Pulmonary Disease in Patients Without HIV Infection
2004
Refining the Global Spatial Limits of Dengue Virus Transmission by Evidence-Based Consensus
2012 Standout
Heart transplantation for Q fever endocarditis
1994
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
Nontuberculous Mycobacterial Infection in Hematopoietic Stem Cell and Solid Organ Transplant Recipients
2004
Ribosomal antibiotics: structural basis for resistance, synergism and selectivity
2004 StandoutNobel
Immunity to fungal infections
2011 Standout
The evolution and role of macrolides in infectious diseases
2002
Septic Arthritis of the Pubic Symphysis
2003
Coccidioidomycosis in Human Immunodeficiency Virus–Infected Persons in Arizona, 1994–1997: Incidence, Risk Factors, and Prevention
2000
Serologic Imprint of Dengue Virus in Urban Haiti: Characterization of Humoral Immunity to Dengue in Infants and Young Children
2011
DisseminatedMycobacterium aviumComplex Disease among Patients Infected with Human Immunodeficiency Virus, 1985–2000
2001
A Controlled Trial of Itraconazole as Primary Prophylaxis for Systemic Fungal Infections in Patients with Advanced Human Immunodeficiency Virus Infection in Thailand
2002
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Histoplasmosis after Treatment with Anti–Tumor Necrosis Factor-α Therapy
2003
The Pharmacokinetics and Pharmacodynamics of Pulmonary Mycobacterium avium Complex Disease Treatment
2012
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
Risk Factors for Rifampin Mono-resistant Tuberculosis
1998
An Official American Thoracic Society Statement: Treatment of Fungal Infections in Adult Pulmonary and Critical Care Patients
2010
Guidelines for the Early Management of Adults With Ischemic Stroke
2007 Standout
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Susceptibility of Coxiella burnetii to pefloxacin and ofloxacin in ovo and in persistently infected L929 cells
1989
The Macrolides: Erythromycin, Clarithromycin, and Azithromycin
1999
Histoplasmosis: a Clinical and Laboratory Update
2007
Sulfatase-activated fluorophores for rapid discrimination of mycobacterial species and strains
2013 StandoutNobel
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
23S rRNA base pair 2057–2611 determines ketolide susceptibility and fitness cost of the macrolide resistance mutation 2058A→G
2005 StandoutNobel
In vitro susceptibility of Coxiella burnetii to antibiotics, including several quinolones
1987
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
ZOONOTIC ENDOCARDITIS
1993
Epidemiology of HIV-associated cryptococcosis in France (1985–2001)
2004
Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision
2017 Standout
The macrolides
2002
Guidelines for Preventing Opportunistic Infections among HIV-Infected Persons—2002: Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America*
2002
CpG Still Rocks! Update on an Accidental Drug
2012
Q Fever
1999 Standout
Optimizing ethambutol dosing among HIV/tuberculosis co-infected patients: a population pharmacokinetic modelling and simulation study
2019 StandoutNobel
2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adultsa
2015 Standout
Approaches to Malaria Vaccine Development Using the Retrospectroscope
2009
Antifolate Activity of Epigallocatechin Gallate against Stenotrophomonas maltophilia
2005 Standout
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Subcellular Partitioning and Intramacrophage Selectivity of Antimicrobial Compounds against Mycobacterium tuberculosis
2017 StandoutNobel
Antibiotic susceptibilities of two Coxiella burnetii isolates implicated in distinct clinical syndromes
1989
Ethambutol Optimal Clinical Dose and Susceptibility Breakpoint Identification by Use of a Novel Pharmacokinetic-Pharmacodynamic Model of Disseminated Intracellular Mycobacterium avium
2010
Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
2012 Standout
ANTIBIOTICS TARGETING RIBOSOMES: Resistance, Selectivity, Synergism, and Cellular Regulation
2005 StandoutNobel
Endocarditis Due to Rare and Fastidious Bacteria
2001 Standout
Guidelines for Treatment of Candidiasis
2004 Standout
Microbiological and Clinical Aspects of Infection Associated with Stenotrophomonas maltophilia
1998 Standout
Hidden Killers: Human Fungal Infections
2012 Standout
Clinical Practice Guidelines for the Management of Patients with Histoplasmosis: 2007 Update by the Infectious Diseases Society of America
2007 Standout
Works of Mark A. Pierce being referenced
A Randomized Trial of Clarithromycin as Prophylaxis against DisseminatedMycobacterium aviumComplex Infection in Patients with Advanced Acquired Immunodeficiency Syndrome
1996
Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic
1997
A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel® with CPG 7909, using two different formulations and dosing intervals
2009
A Multicenter Comparative Study of the in vitro Activity of Fleroxacin and Other Antimicrobial Agents
1995
Itraconazole Prophylaxis for Fungal Infections in Patients with Advanced Human Immunodeficiency Virus Infection: Randomized, Placebo‐Controlled, Double‐Blind Study
1999
Phase 1 Study of a Combination AMA1 Blood Stage Malaria Vaccine in Malian Children
2008
Case Report: Q Fever Endocarditis
1986
Evaluating Contrast-Enhancing Brain Lesions in Patients with AIDS by Using Positron Emission Tomography
1995
Anti-Apical-Membrane-Antigen-1 Antibody Is More Effective than Anti-42-Kilodalton-Merozoite-Surface-Protein-1 Antibody in Inhibiting Plasmodium falciparum Growth, as Determined by the In Vitro Growth Inhibition Assay
2009
Osteomyelitis of the pubic symphysis in athletes: a case report and literature review.
1995